ACE2 Antibody [3F1] Cat. No.: 10-604

Figure 1 Western Blot Validation of ACE2
Human kidney probed with ACE2 antibody [3F1], 10-604, at 1:1000 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C. See high quality image.

Figure 2 Immunofluorescence Validation of ACE2 in MCF-7 cells
IF (ICC) staining with ACE2 antibody [3F1], 10-604, at 1:300 in MCF-7 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS. See high quality image.

Figure 3 Immunofluorescence Validation of ACE2 in HepG2 cells
IF (ICC) staining with ACE2 antibody [3F1], 10-604, at 1:300 in HepG2 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS. See high quality image.

Figure 4 Immunohistochemistry Validation of ACE2 in Human Breast Carcinoma Tissue
Paraformaldehyde-fixed and paraffin-embedded human breast carcinoma tissue incubated with ACE2 antibody [3F1], 10-604, at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin. See high quality image.

Figure 5 Immunohistochemistry Validation of ACE2 in Human Kidney Tissue
Paraformaldehyde-fixed and paraffin-embedded human kidney tissue incubated with ACE2 antibody [3F1], 10-604, at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin. See high quality image.

Figure 6 Immunohistochemistry Validation of ACE2 in Mouse Kidney Tissue
Paraformaldehyde-fixed and paraffin-embedded mouse kidney tissue incubated with ACE2 antibody [3F1], 10-604, at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin. See high quality image.